Shining a light on depression: new therapy shows promise

NCT ID NCT06934135

Completed Symptom relief Sponsor: NeuroThera DE Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new, non-invasive treatment for major depression called transcranial photobiomodulation (tPBM), which uses near-infrared light on the scalp. Fifty adults with depression received either real light therapy or a sham treatment three times a week for six weeks. The goal was to see if the light therapy could safely reduce depression symptoms and improve brain function.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEPRESSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

anxiety disorder Depression depressive disorder major depressive disorder Psychological Well-Being

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DEPRESSION DEPRESSION, ANXIETY DEPRESSIVE DISORDER DEPRESSIVE DISORDER, MAJOR

Contacts and locations

Locations

Clinica Vesalio

Lima, 15036, Peru
Hospital Nacional Guillermo Almenara Irigoyen

Lima, L01, Peru

More trials for these conditions

Other studies related to the condition(s) this trial covers.